QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

23,210 signal articles · 358 in last 24h · 110,905 total before filter · latest 44m ago
358last 24h
2350last 7d
424● bullish (7d)
217● bearish (7d)
202publishers
AllMacro261Earnings1424M&A98Regulatory17Product16Analyst22
✕ clear all filtersticker: BSXSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Boston Scientific Lawsuits Put Electrophysiology Outlook And Valuation In Focus
Simply Wall St.101d agobearish
Boston Scientific Lawsuits Put Electrophysiology Outlook And Valuation In Focus

Multiple securities class action lawsuits have been filed against Boston Scientific (NYSE:BSX), alleging misleading statements about the sustainability of U.S. electrophysiology growth. The cases focus on disclosures related to a key business segment and whether investors were given an accurate view of growth prospects. Several court ordered and attorney set deadlines are approaching for shareholders who may wish to participate in these actions. Boston Scientific is a large medical device...

Boston Scientific Corporation (BSX): Billionaire Tom Steyer Is Loading Up on This Stock
Insider Monkey101d agoneutral
Boston Scientific Corporation (BSX): Billionaire Tom Steyer Is Loading Up on This Stock

We just covered Billionaire Tom Steyer’s 10 Stock Picks with Huge Upside Potential and Boston Scientific Corporation (NYSE:BSX) ranks 9th on this list. Boston Scientific Corporation (NYSE:BSX) has consistently featured in the 13F portfolio of Farallon Capital since the third quarter of 2020. Back then, this position comprised just under 8.3 million shares. The fund steadily […]

Jim Cramer on Boston Scientific: “I Think They Can Come Back”
Insider Monkey104d agoneutral
Jim Cramer on Boston Scientific: “I Think They Can Come Back”

Boston Scientific Corporation (NYSE:BSX) was among the stocks Jim Cramer covered on Mad Money as he discussed the wave of IPOs being the market’s possible biggest threat. Answering a caller’s query about the stock, Cramer commented: Well, the competition just got too strong for Boston Scientific. They’re always one step out of the posse, and […]